PRIMA Device for Geographic Atrophy Restores Vision to Patients Once Considered Blind
PRIMA Device for Geographic Atrophy Offers Hope to the Blind
In a groundbreaking medical breakthrough, scientists have unveiled the PRIMA device for geographic atrophy, a revolutionary implant that restores partial vision to patients suffering from age-related retinal degeneration.
This tiny device, measuring less than 2 millimeters, has enabled patients who were previously blind to see letters, numbers, and even words again, redefining the limits of ophthalmic innovation.
How the PRIMA Device for Geographic Atrophy Works
The PRIMA device integrates microchip technology with artificial intelligence to recreate visual perception.
After the implant is placed inside the retina, patients wear augmented reality glasses equipped with a camera linked to a small computer worn on the waist.
The camera captures images and sends them to the implant, while the AI system processes the visual data, converting it into electrical signals that travel through the retina and optic nerve to the brain — allowing the patient to “see” again.
Remarkable Results from Global Clinical Trials
According to a study published in the Journal of the American Medical Association (JAMA), 84% of patients who received the PRIMA device for geographic atrophy were able to read letters, numbers, and words, a task that had been impossible before implantation.
On average, participants could read five lines on a standard vision test chart, compared to complete blindness prior to the procedure.
The international study involved 38 patients across five countries — the United Kingdom, France, Italy, the Netherlands, and others.
Successful Trials at Moorfields Eye Hospital in London
The initial trials of the PRIMA device were conducted three years ago at Moorfields Eye Hospital in London, one of the world’s leading centers for ophthalmic research.
Doctors hailed the device as a milestone in treating age-related retinal disorders, particularly geographic atrophy, a condition that affects over five million people worldwide and currently has no cure.
A New Era in Vision Restoration through AI and Innovation
Experts believe that the PRIMA device for geographic atrophy marks the beginning of a new era in AI-powered vision restoration, offering a realistic alternative to traditional eye transplants or stem cell therapy.
Future versions of the device are expected to enhance clarity and range, potentially helping patients with total blindness regain functional vision.
For millions suffering from degenerative eye diseases, the PRIMA implant represents more than a medical innovation — it’s a return to light, independence, and hope.
Read more:
